- Home
- ALTO vs HRTX Comparison
ALTO vs HRTX Comparison
Compare ALTO & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALTO | HRTX |
|---|---|---|
| Founded | 2003 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 194.1M | 203.5M |
| IPO Year | N/A | 1987 |
Fundamental Metrics
Financial Performance| Metric | ALTO | HRTX |
|---|---|---|
| Price | $2.83 | $1.31 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $5.50 | $4.50 |
| AVG Volume (30 Days) | 1.5M | ★ 1.9M |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $922,309,000.00 | $155,097,000.00 |
| Revenue This Year | N/A | $8.98 |
| Revenue Next Year | $8.07 | $11.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.60 |
| 52 Week Low | $0.76 | $1.00 |
| 52 Week High | $3.18 | $2.68 |
Technical Indicators
Market Signals| Indicator | ALTO | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | 59.74 | 54.20 |
| Support Level | $2.91 | $1.26 |
| Resistance Level | $3.18 | $1.40 |
| Average True Range (ATR) | 0.23 | 0.08 |
| MACD | -0.01 | -0.01 |
| Stochastic Oscillator | 61.10 | 56.01 |
Price Performance
Historical ComparisonAbout ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include food and beverage companies and consumer products manufacturers and distributors. The company operates under four segments: Marketing and distribution, Pekin Campus production, Western production, and Corporate.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.